Week

Genomic sequences processed in minutes, rather than weeks

A new computational tool developed at the Department of Energy's Pacific Northwest National Laboratory is speeding up our understanding of the machinery of life -- bringing us one step closer to curing diseases, finding safer ways to clean the environment and protecting the country against biological threats. ScalaBLAST is a sophisticated "sequence alignment tool" that can divide the work...

Bacteria can survive for weeks on hospital surfaces

A major cause of hospital-acquired infections can persist for days and even weeks on environmental surfaces found in healthcare settings, including bed linens, computer keyboard covers and acrylic fingernails, according to research presented today at the 105th General Meeting of the American Society for Microbiology. Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of ho...

New influenza vaccine takes weeks to mass produce

Using cell-based methods researchers have developed a commercially viable method for mass producing effective vaccines against potential pandemic influenza strains in weeks instead of the months required for traditional egg-based vaccines. They report their results today at the 2006 ASM Biodefense Research The next flu pandemic could happen any time," says Keyang Wang, a scientist at Prote...

Week at Biology Products

3-4 Week Baby Rabbit Complement Sterile from Pel-Freez Biologicals

Description:Blood is aseptically collected via cardiac puncture from 3 to 4 week old rabbits (New Zealand White, mixed sex). It is then centrifuged and frozen at -70C. The complement is thawed, pooled, sterile filtered and bottled at 4C then stored at -70C. DIRECT SALES FROM PEL-FREEZ BIOLOGICALS! IF YOU HAVE ALWAYS USED PEL-FREEZ COMPLEMENT, YOU CAN NOW BUY DIRECTLY FROM THE SOURCE! FORMER DISTRIBUTORS AND...
Company:Pel-Freez Biologicals

Week at Biology Technology

Ready to leave? Why you shouldn't give two weeks' notice

The "Exit Stage Right" article on Why? Because giving two week's notice (let alone four week's notice) went out with nickel beers. The article also needs a reality check on some of its observations and assertions of how life is in today's corporate...

Two-week notices: People are still concerned

Some don't even know who the...

Digital Healthcare Conference marks Wisconsin's Healthcare IT Week

Healthcare IT Week recognizes the contribution that information technology makes to keeping people health...

Employees debate ethics of giving two weeks' notice

About a year ago, I wrote a column criticizing an "advice article" in the Chicago Tribune about the practice of giving two-week notices when leaving a company. ( ) It was published both on ePrairie and with the Wisconsin Technology Network (WTN). The Wisconsin copy was left...

S.C. Johnson lands in No. 2 spot in Information Week 500 list

Seven other Wisconsin organzations, other than S.C. Johnson, made this year's list.<br...

More>>

Week at Medicine News

Glaxo launches pills to help smokers quit in 7-12 weeks

GLAXO SmithKline India has launched an oral treatment for smoking, called Zyban. The pill (generic - Bupropion Hydrochloride) is reportedly the first product aimed at stopping smoking and is available at Rs. 40 per tablet. Speaking to newspersons, Mr. Kalyanasundaram, Director (Pharmaceuticals), Glaxo India Ltd, said the complete treatment osts about Rs. 5000 and takes about 7-12 weeks....

First head-to-head trials of once weekly Fosamax and Actonel therapies

The drug major Merck has launched the first two head-to-head clinical trials that compare the efficacy and tolerability of Fosamax (alendronate) once weekly 70mg and Actonel (risedronate) once-weekly 35mg. Fosamax and Actonel, both bisphosphonates indicated for the treatment of osteoporosis in post menopausal women are co-marketed by Aventis and Procter & Gamble through the Alliance for//...

Answer on SARS 3 to 4 weeks away

The World Health Organization said that it should take three to four weeks for it to fully understands about SARS in China. Since mid-February, an international team from WHO has been working with the Beijing government and now WHO are a full partner with China in the investigation of SARS. China has 1,435 cases of severe acute respiratory syndrome - SARS, accounting for about half of the...

World SARS-free within weeks

The World Health Organisation said the world should be free of the deadly SARS virus within the next two to three weeks, but warned the disease could emerge in China again next winter. "All countries are probably now going to be SARS-free within the next two-to-three weeks. SARS will be gone, we believe, from human populations," says WHO. Taiwan and Toronto -- the only two areas still reg...

An hour of exercise a week cuts hypertension

High blood pressure is becoming more common around the world. It can lead to strokes, heart attacks and kidney failure.// Many guidelines currently call for anywhere between half an hour and an hour of moderate exercise on most days of the week to reduce the risk of heart disease, cancer, diabetes and obesity.Researchers from Japan, tested 207 men and women who had high blood pressure...

More>>

Week at Medicine Products

Focus 1-2 Week Lenses

Description:The convenience of disposable type lenses available in a wide variety of options. Recommended replacement schedule: one week for extended wear, two weeks for daily wear....
Company:CIBA Vision

Week at Medicine Technology

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 10, 2007 - BusinessWeekpublished an article on July 6 discussing the race bypharmaceutical and biotechnology companies to be first to bring tomarket an effective angiogenesis treatment for cardiovasculardisease. While angiogenesis therapies are being pursued bySanofi-Aventis, Boston Scientific, Baxter, and Genzyme, amongothers, the article highlights a...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

EXCLAIM is the First International Study to Show That ExtendedThromboprophylaxis Reduces VTE Risk in Acutely-ill Medical PatientsWith a Statistically Significant 44% PARIS, July 8, 2007 /PRNewswire-FirstCall/ --Sanofi-aventisannounced today the results of the EXCLAIM (EXtended CLinicalprophylaxis in Acutely Ill Medical patients) study, which showedthe benefit of extended prophylaxi...

TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials

Data Published in The Lancet on TMC125, an Investigational NNRTIfrom Tibotec YARDLEY, Pa., July 05, 2007 /PRNewswire/ -- Data from twoongoing Phase 3 studies (DUET-1 and DUET-2) showed significantlymore HIV-1 adult patients with documented non-nucleoside reversetranscriptase inhibitor (NNRTI) and protease inhibitor (PI)resistance reached an undetectable viral load (defined as achievingco...

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek todaypublished an article discussing the race by pharmaceutical andbiotechnology companies to be first to bring to market an effectiveangiogenesis treatment for cardiovascular disease. Whileangiogenesis therapies are being pursued by Sanofi-Aventis, BostonScientific, Baxter, and Genzyme, among others, the articlehighlights a very...

A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients

Final Results from Exploratory Phase IIa Clinical Trial in Type 2Diabetes Patients Announced TORONTO, June 28, 2007 /PRNewswire-FirstCall/ - TransitionTherapeutics Inc. ("Transition") , today announces the results fromits exploratory Phase IIa clinical trial indicating that 4-weeks ofdaily treatments with gastrin-based therapy, E1-I.N.T.(TM), showedsustained reductions in blood glucose co...

More>>